Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Resistant Prostatic Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05682443
What this trial is testing

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
OncoC4, Inc. 148
Post-approval studies (Phase 4)Active Not RecruitingNCT04597125
What this trial is testing

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Bayer 654
Testing effectiveness (Phase 2)Study completedNCT02090114
What this trial is testing

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 112
Early research (Phase 1)Ended earlyNCT03137758
What this trial is testing

A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc 12
Not applicableStudy completedNCT03672396
What this trial is testing

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerAndrogen Deprivation Therapy
UNC Lineberger Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02430480
What this trial is testing

Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 39
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Early research (Phase 1)Study completedNCT01162395
What this trial is testing

Open Label Prostate Cancer Study

Who this might be right for
Prostate Cancer
AstraZeneca 64
Early research (Phase 1)Ended earlyNCT02911467
What this trial is testing

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Rahul Aggarwal 8
Not applicableNot Yet RecruitingNCT07724080
What this trial is testing

Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer

Who this might be right for
Prostate CancerMuscle Loss
University of Bath 40
Testing effectiveness (Phase 2)Study completedNCT01534052
What this trial is testing

Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)Study completedNCT02429193
What this trial is testing

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

Who this might be right for
Castration-resistant Prostate Cancer
University Health Network, Toronto 16
Large-scale testing (Phase 3)Active Not RecruitingNCT06691984
What this trial is testing

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 707
Large-scale testing (Phase 3)WithdrawnNCT05098327
What this trial is testing

Pioglitazone and Insulin Resistance in ADT

Who this might be right for
Prostate CancerInsulin ResistanceDiabetes Mellitus, Type 2+1 more
State University of New York at Buffalo
Very early researchWithdrawnNCT04658849
What this trial is testing

Insulin Resistance Following ADT for Prostate CA

Who this might be right for
Insulin ResistanceProstate Cancer
St. Louis University
Testing effectiveness (Phase 2)Looking for participantsNCT07745361
What this trial is testing

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate CancerProstate Cancer+1 more
Monte Rosa Therapeutics, Inc 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06836726
What this trial is testing

Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
University Health Network, Toronto 35
Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Early research (Phase 1)Study completedNCT02924766
What this trial is testing

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 34
Next Page